Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients
Dementia and Geriatric Cognitive Disorders · 2022 · 51 (3) · 271-278
DOI: 10.1159/000525618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dementia and Geriatric Cognitive Disorders, online erschienen am 18.07.2022. Verfasst von Daniela Renftle und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Apraxias, Dementia, Parkinson Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Introduction
Ideomotor apraxia, a disorder of skilled movements affecting limbs and/or face, can be seen in patients with Parkinson’s disease (PD), yet tests of apraxia in PD are rare. The aim of this project was to evaluate the psychometric properties and validity of the Dementia Apraxia Test (DATE) in a PD sample.
Methods
118 PD patients were included. Besides DATE performance, motor and non-motor burden, cognition, and activity of daily living (ADL) function were assessed. Patients were classified as cognitively impaired (n = 41) or non-cognitively impaired (n = 77).
Results
Interrater reliability of the DATE (sub-)scores between video ratings and on-site ratings by the investigator was good (0.81 ≤ rk ≤ 0.87). Items were mostly easy to perform, especially the buccofacial apraxia items, which had also low discriminatory power. DATE scores were associated with cognition and ADL function. DATE performance was confounded by motor impairment and patients’ age; however, when analysed for both cognitive groups separately, the correlation between DATE and motor performance was not significant. Discussion/Conclusion: The DATE seems to be an objective and predominantly valid apraxia screening tool for PD patients, with a few items needing revision. Due to the potential effect of motor impairment and age, standardized scores adjusting for these confounders are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.
- Department of Psychology, University of Calgary, Calgary, Alberta, Canada.
- Clinic of Neurology with Translational Neurology, University Hospital Münster, Münster, Germany.
- IB Hochschule für Gesundheit und Soziales, Stuttgart, Germany.
Zitieren
APA
Renftle, D., Becker, S., Brockmann, K., Gasser, T., Michaelis, K., Solbrig, S., Sulzer, P., Johnen, A., & Liepelt-Scarfone, I. (2022). Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients. Dementia and Geriatric Cognitive Disorders, 51(3), 271-278. https://doi.org/10.1159/000525618
Vancouver
Renftle D, Becker S, Brockmann K, Gasser T, Michaelis K, Solbrig S, et al. Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients. Dementia and Geriatric Cognitive Disorders. 2022;51(3):271-278. doi:10.1159/000525618
BibTeX
@article{Renftle2022,
author = {Renftle, Daniela and Becker, Sara and Brockmann, Kathrin and Gasser, Thomas and Michaelis, Katja and Solbrig, Susanne and Sulzer, Patricia and Johnen, Andreas and Liepelt-Scarfone, Inga},
title = {Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients},
journal = {Dementia and Geriatric Cognitive Disorders},
year = {2022},
volume = {51},
number = {3},
pages = {271--278},
doi = {10.1159/000525618}
}
EUVIMED